Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31069783 | 1.00 | NPC1 (0.66) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| SCHEMBL21351775 | 1.00 | NPC1 (0.66) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| SCHEMBL30106823 | 1.00 | NPC1 (0.66) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| SCHEMBL14148163 | 1.00 | NPC1 (0.66) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| SCHEMBL918871 | 1.00 | NPC1 (0.66) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| SCHEMBL245303 | 1.00 | NPC1 (0.66) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| SCHEMBL12786269 | 0.98 | NPC1 (0.64) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| Hydrochloric Acid SCHEMBL7183038 | 0.97 | NPC1 (0.62) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| Hydrochloric Acid SCHEMBL7171153 | 0.97 | NPC1 (0.62) | NPC1MAPTRAB9ASMN1; SMN2MEN1 | |
| Hydrochloric Acid SCHEMBL7182624 | 0.97 | NPC1 (0.62) | NPC1MAPTRAB9ASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026047173-A1 | PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF | Terra Mater BV (BE) | 2026-03-05 | — | — | WO | claimed |
| EP-4622945-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2025-10-01 | — | — | EP | claimed |
| CN-120040461-A | Spirobarbitudes compound, preparation method and application | 北京工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-120040462-A | Spiropyrazinone compound, preparation method and application | 北京工业大学 | 2025-05-27 | — | — | CN | claimed |
| US-20250092008-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-03-20 | — | — | US | claimed |
| EP-4384509-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO Pharmaceutical Co., Ltd. (JP) | 2024-06-19 | — | — | EP | claimed |
| WO-2024110575-A1 | OLIGOMERISATION OF ALCOHOLS | Terra Mater BV (BE) | 2024-05-30 | — | — | WO | claimed |
| CN-116813643-A | Chiral oxo-bridged oxazolyl heterocyclic compound and preparation method thereof | 北京工业大学 | 2023-09-29 | — | — | CN | claimed |
| WO-2023017813-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2023-02-16 | — | — | WO | claimed |
| US-8735586-B2 | Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles | SANOFI (FR) | 2014-05-27 | — | — | US | claimed |
| US-20100216988-A1 | Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles | SANOFI-AVENTIS (FR) | 2010-08-26 | — | — | US | claimed |
| EP-2173747-A1 | A REGIOSELECTIVE METAL CATALYZED SYNTHESIS OF ANNELATED BENZIMIDAZOLES AND AZABENZIMIDAZOLES | Sanofi-Aventis (FR) | 2010-04-14 | — | — | EP | claimed |
| EP-2173721-A1 | A REGIOSELECTIVE COPPER CATALYZED SYNTHESIS OF BENZIMIDAZOLES AND AZABENZIMIDAZOLES | Sanofi-Aventis (FR) | 2010-04-14 | — | — | EP | claimed |
| US-7524594-B2 | Photosensitive dielectric resin compositions, films formed therefrom and semiconductor and display devices encompassing such films | PROMERUS LLC (US) | 2009-04-28 | — | — | US | claimed |
| WO-2009000413-A1 | A REGIOSELECTIVE COPPER CATALYZED SYNTHESIS OF BENZIMIDAZOLES AND AZABENZIMIDAZOLES | SANOFI-AVENTIS (FR) | 2008-12-31 | — | — | WO | claimed |
| WO-2009000412-A1 | A REGIOSELECTIVE METAL CATALYZED SYNTHESIS OF ANNELATED BENZIMIDAZOLES AND AZABENZIMIDAZOLES | SANOFI AVENTIS (FR) | 2008-12-31 | — | — | WO | claimed |
| EP-1778759-B1 | PHOTOSENSITIVE DIELECTRIC RESIN COMPOSITIONS AND THEIR USES | PROMERUS LLC (US) | 2008-11-12 | — | — | EP | claimed |
| EP-1778759-A1 | PHOTOSENSITIVE DIELECTRIC RESIN COMPOSITIONS AND THEIR USES | Promerus, LLC (US) | 2007-05-02 | — | — | EP | claimed |
| WO-2006017035-A1 | PHOTOSENSITIVE DIELECTRIC RESIN COMPOSITIONS AND THEIR USES | PROMERUS LLC (US) | 2006-02-16 | — | — | WO | claimed |
| US-20060008734-A1 | Photosensitive dielectric resin compositions, films formed therefrom and semiconductor and display devices encompassing such films | SUMITOMO BAKELITE CO., LTD. (JP) | 2006-01-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092008-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | PTGER4, LTB4R2, EPB41 | NPC1 3834/4885MAPT 4859/4885RAB9A 4333/4885 |
| US-20100216988-A1 | Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles | AZI2, NIT2, NISCH | NPC1 3174/4885MAPT 4209/4885RAB9A 2309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.